Circulating metabolites and the development of type 2 diabetes in Chinese adults
暂无分享,去创建一个
R. Clarke | Zhengming Chen | Junshi Chen | Yu Guo | Liming Li | M. Holmes | C. Kartsonaki | D. Jin | Canqing Yu | Ling Yang | I. Millwood | Yiping Chen | J. Lv | H. Du | F. Bragg | D. Avery | P. Pei | M. Hill | D. Schmidt
[1] Jennifer G. Robinson,et al. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies , 2021, Diabetes Care.
[2] T. Lehtimäki,et al. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts , 2019, bioRxiv.
[3] R. Collins,et al. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke , 2018, Journal of the American College of Cardiology.
[4] T. Hansen,et al. Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels , 2017, Diabetologia.
[5] Inês Barroso,et al. Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.
[6] F. Hu,et al. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. , 2016, International journal of epidemiology.
[7] Frank B Hu,et al. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.
[8] R. Collins,et al. Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[9] R. Collins,et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.
[10] A. Jenkins,et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.
[11] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[12] R. L. Prentice,et al. A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .